Inhibition of miR-155 Attenuates CD14+ Monocyte-Mediated Inflammatory Response and Oxidative Stress in Psoriasis Through TLR4/MyD88/NF-κB Signaling Pathway
DOI: https://doi.org/10.2147/CCID.S350711
2022-02-09
Abstract:Jiajie Li, Yanmin Liu, Yue Cao, Juanjuan Wang, Xingcheng Zhao, Juanjuan Jiao, Junqin Li, Kaiming Zhang, Guohua Yin Shanxi Key Laboratory of Stem Cell for Immunological Dermatosis, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, 030009, Shanxi Province, People's Republic of China Correspondence: Guohua Yin, Tel +86 0351-5656079, Email Purpose: Previous studies showed the link of CD14 + monocytes to inflammation and oxidation in psoriasis. In the present study, we investigated the regulatory role of miR-155 in CD14 + monocyte function in psoriasis. Materials and Methods: CD14 + monocytes were isolated from peripheral blood by magnetic bead separation method and its function was assessed following silence of miR-155 by lentivirus transfection with or without inhibition of TLR4 pathway. CCK8 and EdU were used to assess the proliferation of CD14 + monocytes. Expression levels of SOCS1, TLR4 and MyD88 proteins were determined by Western blotting, while expression levels of IL-6, TNF-α, ROS, MDA and T-AOC were measured by ELISA kit. The expression levels of mRNA for miR-155, NF-κB and its subunit NF-κB-p65 were assessed by q-PCR. Results: The results showed that compared with normal control CD14 + monocytes, the expression levels of miR-155, NF-κB and NF-κB-p65, TLR4, MyD88 and IL-6, TNF-α were increased, while expression levels of SOCS1 were decreased in CD14 + monocytes from psoriatic patients. Enhanced cell proliferation and oxidation were also observed in CD14 + monocytes from psoriatic patients. Inhibition of miR-155 partially corrected the abnormalities of cell proliferation and expression levels of biomarkers mentioned above in CD14 + monocytes from psoriatic patients. Inhibitions of both TLR4 pathway and miR-155 further corrected abnormalities of proliferation and the above biomarkers in CD14 + monocytes from psoriatic patients. Conclusion: These results suggest that increased expression levels of miR-155 contribute to CD14 + monocyte-mediated inflammation and oxidation in psoriasis via TLR4 pathway. Keywords: psoriasis CD14 + monocytes, miR-155, TLR4 pathway, inflammatory, oxidation Psoriasis is a chronic immune inflammatory skin disease characterized by infiltration of inflammatory cells such as monocytes and neutrophils, and epidermal hyperproliferation. 1 Monocytes are heterogeneous and have multiple subpopulations. CD14 + monocytes belong to the classic subpopulations and participate in the regulation of diseases. 2 The mechanisms of CD14 + monocyte-mediated diseases are complex. Psoriatic patients exhibit an increased number of monocytes in the peripheral blood. Monocytes can be recruited from the blood to the inflamed skin site of psoriasis through CCR6, leading to amplification of the inflammatory response. 3 Monocytes can also migrate from the inflamed skin site to the peripheral blood and express higher levels of TLRs. 4 In psoriasis, CD14 + monocytes can release high levels of TNF-α, IL-6 and IL-10, the increase of TNF-α and IL-6 is positively correlated with the severity of psoriasis, and the increase of IL-10 plays a positive role in the treatment of psoriasis. 5,6 TLRs, which belong to type I transmembrane proteins, are a group of evolutionarily highly conserved pattern recognition receptors that can be activated by a variety of pathology-associated molecules and participate in the occurrence and development of diseases. 7 TLR4, a member of the TLR family, is rich in extracellular leucine sequences, which can be activated by bacterial lipopolysaccharide (LPS) to initiate a cascade of protein reactions, inducing the production of pro-inflammatory cytokines, consequently leading to inflammatory and immune responses. LPS binds to the LPS-binding protein (LBP) and is transferred to the CD14 cluster, then recognized and bound by the myeloid differentiation factor-2 (MD-2) on TLR4, forming the LPS/CD14/MD-2/TLR4 complex, which activates intracellular signaling pathways, TLR4/MyD88/NF-κB and TLR4/TRIF/IRF3. 8 There are five subtypes of NF-κB in humans, and P65 is an important subunit of NF-κB, which is activated in inflammation. 9 In TLR4/MyD88/NF-κB signaling pathway, the downstream of NF-κB is activated through a series of chemical reactions, promoting the release of inflammatory cytokines such as IL-1β, TNF-α and IL-6. 10 Over-activation of NF-κB signaling pathway can disturb the oxidative balance, leading to the accumulation of peroxidation products such as reactive oxygen species (ROS), and the decrease of antioxidant T-AOC, resulting in oxidative stress and further -Abstract Truncated-